Teva layoffs 2022?

Quote

anonymous said:
Did you even look up your question before asking? You are aware the internet is a useful tool for finding information? First one that comes to mind is Forrest Pharmaceuticals in i think 2010. I mentioned Pfizer/Exact Sciences which is still currently ongoing (Exact Science contracted a salesforce with Pfizer. Pfizer broke the contract and laid them all off). etc. There are many examples. Remember you cannot lay off reps that are also in contention for presidents club because reps will sue over companies not wanting to bonuses. There are also many examples of age discrimination on layoffs with Pfizer, BMS and Merk. Lets not forget Novartis and Lilly laying people off and losing their lawsuit because it was discovered they targeted people on vested money for 401ks. This is why there is a point system applied to each rep when it comes to reorgs and layoffs now. Pay, age, gender, rep location distance when compared to the name of the territory, time with company, etc. Also, you seem to keep forgetting that teva will not replace their sales force with a outsourced sales team like the Medincell LAI team (similar to the pfizer example). Which has been explained to nauseum. But it does not even make common sense. You have new inexperienced uzedy reps calling on only 30% of the current writers of Austedo that are also selling another company's product. Do your really think that Teva is going to replace up to 20% of its Austedo salesforce who know 100% of the targets for years with unproven Uzedy reps? Most uzedy reps have not even called on a single Austedo target yet. They may use them for backfill austedo position, but that's it. Come on man, do you really believe that nonsense you are pushing on here? Seriously how good of a rep can you be if you do not even know how to search something on the internet?
Click to expand...

LOL! He does not even have to surf the web. He can search on cafepharma to find all the lawsuits. I do not think the guy knows what he is talking about. I think he is just saying things to convince himself he is not going to lose his job over Teva messing up with Uzedy. Uzedy Reps are already leaving or are job searching because the writing is on the wall. The fact the FDA is asking for more information means the PI is going to have "red flags" that the competition will pick apart. If it is approved. That disease space has massive competition with new drugs coming out every month for the next year or two. So, even if it does get approved it will be late to market.
 






anonymous said:
FDA isn’t asking for more information
Click to expand...

TV-46000 is based on MedinCell’s BEPO technology, which combines the active drug with copolymers that form a depot after injection that degrades over time, slowly releasing the active ingredients. MedinCell is also testing the technology with ivermectin to see if it can treat COVID-19 and another schizophrenia product for early 2023.

Even if approved, TV-46000 could face a challenging time in the marketplace, as the market for long-acting injectables for schizophrenia – designed to improve patients’ adherence with therapy – has become crowded in the last few years.

A key rival could be Johnson & Johnson’s recently-approved Invega Hafyera (paliperidone), which only needs to be administered twice-yearly, as well as J&J’s older monthly and three-monthly formulations Invega Sustenna and Invega Trinza.

Others jostling for market share include Alkermes’ Aristada (aripiprazole lauroxil), which is administered every six or eight weeks.
 



Everyone keeps calling the Uzedy salesforce a MediCell contract salesforce. Didn't Teva do all the interviewing, hiring, background checks, drug screens, territory placement and new hire onboarding? I don't know about you all, but that sure sounds like a Teva salesforce to me? Teva was simply licensed to sell their product and share in the profits, right?
 



anonymous said:
Everyone keeps calling the Uzedy salesforce a MediCell contract salesforce. Didn't Teva do all the interviewing, hiring, background checks, drug screens, territory placement and new hire onboarding? I don't know about you all, but that sure sounds like a Teva salesforce to me? Teva was simply licensed to sell their product and share in the profits, right?
Click to expand...

No. Teva hired the salesforce to sell 2 LAI drugs from medicell. If both drugs are not approved, don't make it to market or do not turn a profit Teva can break the agreement and let go the salesforce. An most recent example would be Pfizer and Exact Science. Pfizer hired a salesforce to sell cologuard. The product did not make a profit, so Pfizer broke the agreement and let go its cologuard salesforce. Exact science hired some of the Pfizer reps, because they did not have a salesforce to sell cologuard. This is the same exact agreement Teva and Medicell have. Difference is teva hired a much smaller salesforce to sell Uzedy, Uzedy is not approved to be sold yet, if at all. So, the answer to you question is "no". But it also depends on your definition. Are Uzedy reps like the traditional contract salesforce? No. But were they hired by big pharma companies acting like a contract company? "Yes". For the last 5yrs or so we are seeing pharma companies acting like contract companies because there is less financial risk to offering small companies a salesforce rather than buying them for the drug. Teva is doing this to limit debt after acquiring so many companies which carried so many liabilities. Example would be opioids. Teva hires basically a contract salesforce to sell another companies drug. Limits there exposure. This is becoming a more and more common practice as big pharma pipelines are getting smaller.
 



anonymous said:
No. Teva hired the salesforce to sell 2 LAI drugs from medicell. If both drugs are not approved, don't make it to market or do not turn a profit Teva can break the agreement and let go the salesforce. An most recent example would be Pfizer and Exact Science. Pfizer hired a salesforce to sell cologuard. The product did not make a profit, so Pfizer broke the agreement and let go its cologuard salesforce. Exact science hired some of the Pfizer reps, because they did not have a salesforce to sell cologuard. This is the same exact agreement Teva and Medicell have. Difference is teva hired a much smaller salesforce to sell Uzedy, Uzedy is not approved to be sold yet, if at all. So, the answer to you question is "no". But it also depends on your definition. Are Uzedy reps like the traditional contract salesforce? No. But were they hired by big pharma companies acting like a contract company? "Yes". For the last 5yrs or so we are seeing pharma companies acting like contract companies because there is less financial risk to offering small companies a salesforce rather than buying them for the drug. Teva is doing this to limit debt after acquiring so many companies which carried so many liabilities. Example would be opioids. Teva hires basically a contract salesforce to sell another companies drug. Limits there exposure. This is becoming a more and more common practice as big pharma pipelines are getting smaller.
Click to expand...

This wanna be know it all has all the answers...there isn't a contract sales force etc. Teva simply f'd up the approval and now is caught with their pants down. Including all the reps who ran from Austedo to transfer to this dead end role. Sven is creaming in his pants "yes, more layoffs, less overhead, yeah baby, ooooohhhhhh"
 



anonymous said:
No. Teva hired the salesforce to sell 2 LAI drugs from medicell. If both drugs are not approved, don't make it to market or do not turn a profit Teva can break the agreement and let go the salesforce. An most recent example would be Pfizer and Exact Science. Pfizer hired a salesforce to sell cologuard. The product did not make a profit, so Pfizer broke the agreement and let go its cologuard salesforce. Exact science hired some of the Pfizer reps, because they did not have a salesforce to sell cologuard. This is the same exact agreement Teva and Medicell have. Difference is teva hired a much smaller salesforce to sell Uzedy, Uzedy is not approved to be sold yet, if at all. So, the answer to you question is "no". But it also depends on your definition. Are Uzedy reps like the traditional contract salesforce? No. But were they hired by big pharma companies acting like a contract company? "Yes". For the last 5yrs or so we are seeing pharma companies acting like contract companies because there is less financial risk to offering small companies a salesforce rather than buying them for the drug. Teva is doing this to limit debt after acquiring so many companies which carried so many liabilities. Example would be opioids. Teva hires basically a contract salesforce to sell another companies drug. Limits there exposure. This is becoming a more and more common practice as big pharma pipelines are getting smaller.
Click to expand...

Damn, sounds like you stayed at a Holiday Inn Express last night. What a Mr. Know it all you are.
 



anonymous said:
TV-46000 is based on MedinCell’s BEPO technology, which combines the active drug with copolymers that form a depot after injection that degrades over time, slowly releasing the active ingredients. MedinCell is also testing the technology with ivermectin to see if it can treat COVID-19 and another schizophrenia product for early 2023.

Even if approved, TV-46000 could face a challenging time in the marketplace, as the market for long-acting injectables for schizophrenia – designed to improve patients’ adherence with therapy – has become crowded in the last few years.

A key rival could be Johnson & Johnson’s recently-approved Invega Hafyera (paliperidone), which only needs to be administered twice-yearly, as well as J&J’s older monthly and three-monthly formulations Invega Sustenna and Invega Trinza.

Others jostling for market share include Alkermes’ Aristada (aripiprazole lauroxil), which is administered every six or eight weeks.
Click to expand...

The above post could be Uzedy’s epitaph on its headstone in the graveyard of unneeded drugs. Can’t beat 2x a year my friends, not to mention the other 3 month injections! If this drug ever makes it, you guys will be spinning lies all over the territory trying to get a few scraps of Rx’s. You are dead men walking and don’t even know it.
 



anonymous said:
This wanna be know it all has all the answers...there isn't a contract sales force etc. Teva simply f'd up the approval and now is caught with their pants down. Including all the reps who ran from Austedo to transfer to this dead end role. Sven is creaming in his pants "yes, more layoffs, less overhead, yeah baby, ooooohhhhhh"
Click to expand...

Common response by someone who does not understand the business and does not know how to look thing up on the internet. I presented examples and logic behind moves. Tomorrow is Teva's quarterly report. It will show what I have been saying. Teva and Medincell stocks have tanked since the FDA letter. Teva does not have the money to carry a sales team when it has 2 other teams selling the same drug. Two months we will see if uzedy reps are let go or if there is reorg. Because teva only has around $225-250million in cash. A $45-50 million salesforce with no drug is a problem. They can't carry them for 9-12 months. But you are right, sven is in a uncomfortable position
 



anonymous said:
Damn, sounds like you stayed at a Holiday Inn Express last night. What a Mr. Know it all you are.
Click to expand...

Read the reports by hedgefunders. Neurocrine and Teva report this week. I am not saying anything that is not already being discussed. You call me a know it all, but I'm just telling you what many others are reporting.
 



As I said, misses across the board. Miss on revenue, earnings per share and cash flow. In the report is no mention of uzedy. Now medincell is talking about uzedy and hopefully getting it approved to spark its company growth. Just like a company that outsourced its salesforce....NEXT!
 



anonymous said:
As I said, misses across the board. Miss on revenue, earnings per share and cash flow. In the report is no mention of uzedy. Now medincell is talking about uzedy and hopefully getting it approved to spark its company growth. Just like a company that outsourced its salesforce....NEXT!
Click to expand...


lol lol. .
The best job is the one you don’t get.


Lol to the stupid DM. But it worked out.
Enjoy yout lay-off you worthless DM
 






the one thing that uzedy did was show how terrible and lazy the np force is. these people don't work. they drop off a cup of coffee and go. move over losers...uzedy reps are here to stay
 



anonymous said:
the one thing that uzedy did was show how terrible and lazy the np force is. these people don't work. they drop off a cup of coffee and go. move over losers...uzedy reps are here to stay
Click to expand...

If you say so. In my territory 7 offices already kicked the 4 Uzedy reps out. For me it's more about damage control and hand holding with the Uzedy reps. It's not their fault they lack experience and knowledge of the disease state. I think it will be interesting to see if uzedy gets approved, what the relationship will be like for NH and NP with all this hostility teva created.

But with the way you are talking on these forums you must think Uzedy will not get approved.
 



anonymous said:
If you say so. In my territory 7 offices already kicked the 4 Uzedy reps out. For me it's more about damage control and hand holding with the Uzedy reps. It's not their fault they lack experience and knowledge of the disease state. I think it will be interesting to see if uzedy gets approved, what the relationship will be like for NH and NP with all this hostility teva created.

But with the way you are talking on these forums you must think Uzedy will not get approved.
Click to expand...

That Uzedy rep you are talking with is probably somewhere where many places keep opening then closing or changing protocols routinely based on Covid. Many reps ask all the time if they can do lunches or leave snacks, and have heard no for the last couple of years. A new sales rep comes in and asks the question and find out you can because the office re-opened to reps for the hundredth time. So, I would not fault the NP reps for not knowing about snacks/lunches or use it as a way of measuring activity. Quality calls on writers is measured by Rx and percentage to goal. Anyone can bring in coffee and leave a brochure. I see it all the time in the field where a rep drops off a snack and gets a few signatures and then probably heads out to a Yahkee game.
 



anonymous said:
The current gossip is the new LAI did not get approved and "might" be approved in 9-12 months. So they are now repurposing that sales team to sell Austedo with everyone else. Lol! When do you think Teva will have another layoff? I saw a post for Sept. I am betting sooner. I think teva will know in a couple of months if they are gonna get that LAI fda approved. I don't think it will get approved and a reorganization will happen in 2 months. I would love to know other reps perspectives on this
Click to expand...
 



anonymous said:
LOL! He does not even have to surf the web. He can search on cafepharma to find all the lawsuits. I do not think the guy knows what he is talking about. I think he is just saying things to convince himself he is not going to lose his job over Teva messing up with Uzedy. Uzedy Reps are already leaving or are job searching because the writing is on the wall. The fact the FDA is asking for more information means the PI is going to have "red flags" that the competition will pick apart. If it is approved. That disease space has massive competition with new drugs coming out every month for the next year or two. So, even if it does get approved it will be late to market.
Click to expand...
 









Top Bottom
Back
Quote